Dallas, TX (PRWEB) October 06, 2012
The report focuses on the key insights into the biodefense industry. The report is built using data and information sourced from proprietary databases, primary and secondary research, and in-house analysis by GBI Research’s team of industry experts. The report provides an in-depth analysis of the biodefense industry. The report examines the bioterrorist events which have resulted in Research and Development (R&D) in the industry. The pharmaceutical countermeasures and treatments by Europe and the US. The report analysis the work of the industry in terms of past, present and future pharmaceutical research, development and production to counter or treat diseases caused by biological attack.
This report is built using data and information sourced from proprietary databases, primary and secondary research, and in house analysis by GBI Research’s team of industry experts.
GBI Research also analyzed pipeline of category A pathogens namely, anthrax, small pox, viral hemorrhagic fever, plague and tularemia. Anthrax (24%), smallpox (32%) and viral hemorrhagic fever (39%) contributed a total of 95% of the molecules to the biodefense industry pipeline. Viral hemorrhagic fever, anthrax and small pox are among the most researched diseases in the biodefense industry. It is attributable because of scale of destruction that these two pathogens can cause. According to GBI Research analysis, Emergent BioSolutions and SIGA Technologies were awarded a total of 15 contracts between 2007 and 2012.
Reasons to buy
Biodefense Industry – Competitive Landscape
2. Alnylam Pharmaceuticals
3. Bavarian Nordic
4. Cleveland BioLabs
5. Dynavax Technologies Inc.
6. Dynport Vaccine Company LLC (DVC)
7. Elusys Therapeutics
8. Emergent BioSolutions
9. Ichor Medical Systems
12. SIGA Technologies
Major Points form Table Content for Biodefense Industry
Browse more reports on Pharmaceuticals Market.
Contact sales (at) reportsandreports (dot) com for further information.
ReportsnReports.com is an online market research reports library of 200,000+ in-depth studies of 5000+ micro markets.